Ferroglobin - Ferrous Sulfate | VetSafeCare.Com

Syrp.

Ferroglobin

Ferrous Sulfate — ACME Laboratories Ltd.
200mg / 5 ml

Alternatives

15

Routes

PO

Presentations

1

Generic profile Browse alternatives View combinations

Presentations

Syrup · 200mg / 5 ml

200 ml

৳40.25

Dose rules

No structured dose rules are linked to this brand yet.

Dose reference

Human

Adult- Initial therapeutic dose: 3-4½ teaspoonful daily in divided doses or as prescribed by the physician. Maintenance dose: 1½ teaspoonful daily, but if needed up to 1.8g (9 teaspoonful) daily can be given. Children- Under 1 year: ¼ th teaspoonful thrice daily or as directed by physician 1-5 years: 1 teaspoonful thrice daily 6-12 years: 1½ teaspoonful twice daily. Mix with water or fruit juice to avoid temporary staining of teeth. Do not mix with milk.

Clinical notes

Applications:
  • Anaemia
Indication Notes:
Ferrous Sulfate is indicated in the treatment and prevention of iron deficiency anaemia and anaemia of pregnancy where routine administration of iron is necessary.
Avoid In:

N/A

Contraindication Notes:
Iron therapy is contraindicated in haemachromatosis and haemosiderosis.It should not be given to patients receiving repeated blood transfusion or with anaemia not produced by iron deficiency.
Absorption of iron salt and Tetracycline is diminished when taken concomitantly by mouth. If treatment with both drugs is required iron salt should be given 3 hours before or 2 hours after Tetracycline. Absorption of iron is also decreased in the presence of antacids or when taken with tea.
Therapeutic doses of iron may cause gastrointestinal symptoms like diarrhoea, nausea and vomiting. Although iron is better absorbed between meals, side effects can be reduced by taking it with or immediately after food. Continuous administration may sometimes cause constipation. Iron containing liquid medication may cause temporary staining of teeth (this is less likely when diluted).
Should be administered with caution when given to patients with iron storage or iron absorption disease, haemoglobinopathies or existing gastrointestinal disease.